일반기술

노화 방지 고분자 레티노이드, LGA-MVA05

A potent long acting anti-aging agent, LGA-MVA05 [1, Medimin A], have been developed by modifying retinoic acid with PEG(polyethylene glycol). Medimin A possesses a number of interesting profiles, including its higher solubility in water and most organic solvents, thereby a good percutaneous absorption in the skin. Furthermore, a quantitative assay for collagen synthesis in microwell fibroblast culture demonstrated dramatically increase in biological activity relative to other retinoids. Medimin A would be a good anti-aging agent for enhancing bioavailability and stability1. Non-ionic acting form 2. Maximized the absorption and the efficacy 3. Not toxic in various toxicological tests and highly safe 4. Medimin is more stable under UV, pH, temperature and moisture than other retinoids 5. Average wrinkle reduction of Medimin A=35%응용; Cosmetic and medicinal compound for the treatment of acne, removal of wrinkles and topical treatment of certain skin cancers. Product does not have the usual skin irritation(redness) effect of similar compounds

기술정보

기술분류
보건·의료 > 원료의약 대량제조 기술
보유기관
한국산업기술진흥원
기술유형
일반기술
등록일
2000-11-24
데이터 갱신일
정보 없음

상세설명

정보 없음

관련 특허

등록된 관련 특허가 없습니다.